Sara Rockwell, PhD, FASTRO
Professor Emeritus of Therapeutic RadiologyCards
Appointments
Contact Info
Therapeutic Radiology
15 York Street PO Box 208040
New Haven, CT 06513
United States
About
Titles
Professor Emeritus of Therapeutic Radiology
Biography
Sara Rockwell received her B.S. in Physics in from Penn State in 1965 and her Ph.D. in Biophysics from Stanford in 1971. She received postdoctoral training as a Damon Runyon Postdoctoral Fellow at Stanford University and as an Attache de Recherche at the Institut Gustave Roussy in Villejuif, France. In 1974 she joined the faculty of the Yale University School of Medicine and is now Professor of Therapeutic Radiology and Pharmacology. Professor Rockwell taught radiation biology, pharmacology, cancer biology, ethics, and career development skills in several Yale courses and lecture series. Her laboratory research focused on studying the unphysiological microenvironments of cells within solid tumors, with the goal of improving the treatment of cancer. She was among the first researchers to study the effects of hypoxia on the response of malignant cells in culture and solid tumors in vivo to radiation, anticancer drugs, and combined modality therapy and among the first to consider the implications of the hypoxia found in microscopic tumors for the development and evolution of solid malignancies. The results of this research have been published in over 200 scientific publications and presented in over 250 papers at national and international scientific meetings. Professor Rockwell has received numerous awards for her educational and research activities, including election to membership in the Connecticut Academy of Science and Engineering and selection as a Fellow of the American Society for Radiation Oncology (ASTRO).
Professor Rockwell had served on advisory panels for the NIH, DOD, NASA, OSTP and other governmental agencies, the American Cancer Society, other voluntary health organizations, and several universities. She served a two-year term as chair of the NCI Initial Review Group for Clinical Research Studies. She was an active member of several professional societies and had served on the editorial boards of five scientific journals. She served as the Editor-in-Chief of Radiation Research, the official journal of the Radiation Research Society and the preeminent multidisciplinary journal in the radiation sciences.
Dr. Rockwell also served as the Associate Dean for Scientific Affairs for the Yale School of Medicine. She directed the Evaluation Program for the Yale Center for Clinical Investigation (Yale’s CTSA), served on the executive committee of the YCCI, and represented the YCCI on several committees of the national CTSA network. She was also the Medical School’s representative to the Association of American Medical Colleges (AAMC) Group on Research and Development. In addition, she served as Yale University’s designated Faculty Representative to the Federal Demonstration Partnership (FDP) and recently completed a term as the chair of the FDP faculty committee and vice chair of the FDP.
Appointments
Therapeutic Radiology
EmeritusPrimary
Other Departments & Organizations
Education & Training
- Postdoctoral Fellow
- Stanford University (1974)
- Attache de Recherche
- Institut Gustave Roussy (1973)
- Postdoctoral Fellow
- Stanford University (1972)
- PhD
- Stanford University (1971)
- BS
- Penn State University
Research
Overview
We are also working to develop therapeutic strategies which use our knowledge of the metabolic features of these cells improve to cancer therapy. In a collaborative project headed by Dr. Peter Glazer we are examining the effect of the adverse environments within solid tumors on gene expression, mutation rates, and DNA repair. The findings from this project suggest that the environmental stress developing within tumors early in their development may lead to the development of genomic instability and genetic heterogeneity in malignancies. One long-term project examines the metabolism, cytotoxicity, and therapeutic use of bioreductive alkylating agents which are selectively activated to toxic species by cells that are hypoxic.
Another series of studies is examining the role of nutrition and other lifestyle factors in the development, progression, and therapy of cancer. One series of studies examined the implications of subclinical vitamin A deficiency in determining the sensitivity of the lung to radiation injury and in altering the pattern of lung metastases. Another series of ongoing studies has examined the effects of the over-the-counter "alternative medicines" which are widely marketed to and used by many cancer patients. There have been very few rigorous studies examining the effects of these alternative medicines in model tumor systems or examining their interactions with conventional, effective cancer therapeutic agents to assess whether the alternative medicines may potentially be useful, ineffective, or harmful to patients being treated for cancer. Our projects address this problem.
Another project has examined the effects of PHY906, a state-of-the-art formulation of a traditional Chinese herbal medicine, on the intestinal injury induced by radiation, to assess whether PHY906 could be useful in reducing the toxic side effects of pelvic or abdominal radiotherapy.
Ethics of Peer Review: A Guide for Manuscript Reviewers. This web-based course was written for the NIH Office of Research Integrity and is freely available for use in courses on Ethical Issues in Research. The course consists of four elements:
1. Ethics of Peer Review: A Guide for Manuscript Reviewers. (https://medicine.yale.edu/therapeuticradiology/Images/Ethical_Issues_in_Peer_Review_tcm307-34211.pdf) A didactic reading, with references, designed to serve as a handout for participants in the course.
2. A PowerPoint presentation (https://medicine.yale.edu/therapeuticradiology/Images/Ethics_of_Peer_Review-Overview_tcm307-34212.ppt), which can be used by the teacher to cover the material discussed in the handout.
3. A PowerPoint presentation (https://medicine.yale.edu/therapeuticradiology/Images/Ethics_of_Peer_Review-Case_studies_tcm307-34213.ppt), presenting 12 case studies illustrating various ethical issues which might arise during the review of scientific manuscripts.
4. A Guide for the Discussion Leader (https://medicine.yale.edu/therapeuticradiology/Images/Ethics_of_Peer_Review_case_studies-guide_for_discussion_leader_tcm307-34214.pdf), which discusses each case and suggests points for discussion.
Research at a Glance
Yale Co-Authors
Publications Timeline
Joseph Piepmeier, MD, FAANS
Michael Paidas, MD
Publications
2010
WAG‐F8m1Ycb rats harboring a factor VIII gene mutation provide a new animal model for hemophilia A
BOOTH CJ, BROOKS MB, ROCKWELL S, MURPHY JW, RINDER HM, ZELTERMAN D, PAIDAS MJ, COMPTON SR, MARKS PW. WAG‐F8m1Ycb rats harboring a factor VIII gene mutation provide a new animal model for hemophilia A. Journal Of Thrombosis And Haemostasis 2010, 8: 2472-2477. PMID: 20626616, DOI: 10.1111/j.1538-7836.2010.03978.x.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAutosomal locationX chromosomeGenetic basisFactor VIIITertiary structureChromosome 18Point mutationsA1 domainFactor activityGenetic defectsHuman recombinant factor VIIIPartial thromboplastin timeSpecific coagulation factorsNew animal modelNormal prothrombin timeFactor VIII gene mutationsRecombinant factor VIIIMutationsPeripartum deathsGene mutationsCoagulation abnormalitiesSpontaneous bruisingProthrombin timeFemale ratsNovel therapiesAplidin as a potential adjunct to radiation therapy: In vitro studies
Rockwell S, Liu Y. Aplidin as a potential adjunct to radiation therapy: In vitro studies. International Journal Of Radiation Biology 2010, 86: 63-70. PMID: 20070217, PMCID: PMC2837581, DOI: 10.3109/09553000903264531.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsH drug treatmentDrug treatmentPhase II clinical trialEMT6 mouse mammary tumor cellsGy of radiationMouse mammary tumor cellsMammary tumor cellsBystander effectSupraadditive cytotoxicityTherapeutic regimensHematologic malignanciesClinical trialsRadiation therapyModerate hypoxiaActive metaboliteSevere hypoxiaTumor cellsUntreated cellsTreatmentCytotoxicityHypoxiaAplidinKV X-raysCellsMonolayer cultures
2009
Hypoxia and radiation therapy: past history, ongoing research, and future promise.
Rockwell S, Dobrucki IT, Kim EY, Marrison ST, Vu VT. Hypoxia and radiation therapy: past history, ongoing research, and future promise. 2009, 9: 442-58. PMID: 19519402, PMCID: PMC2752413, DOI: 10.2174/156652409788167087.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsClinical trialsSolid tumorsLarge bulky tumorsMicroscopic tumor involvementSmall primary tumorsSelection of patientsOutcome of treatmentNovel therapeutic approachesNew therapeutic targetsEffects of hypoxiaHypoxic tumor cellsTumor oxygen levelsSurgical marginsTumor involvementBulky tumorsTreatment regimensPrimary tumorVascular bedClinical studiesExtensive necrosisRadiation therapyTherapeutic approachesNew agentsTherapeutic targetTherapeutic resistanceThe FDP Faculty Burden Survey.
Rockwell S. The FDP Faculty Burden Survey. Research Management Review 2009, 16: 29-44. PMID: 20563268, PMCID: PMC2887040.Peer-Reviewed Original ResearchCitationsAltmetric
2008
Mapping DNA Adducts of Mitomycin C and Decarbamoyl Mitomycin C in Cell Lines Using Liquid Chromatography/Electrospray Tandem Mass Spectrometry
Paz MM, Ladwa S, Champeil E, Liu Y, Rockwell S, Boamah EK, Bargonetti J, Callahan J, Roach J, Tomasz M. Mapping DNA Adducts of Mitomycin C and Decarbamoyl Mitomycin C in Cell Lines Using Liquid Chromatography/Electrospray Tandem Mass Spectrometry. Chemical Research In Toxicology 2008, 21: 2370-2378. PMID: 19053323, PMCID: PMC2630229, DOI: 10.1021/tx8002615.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsBreast cancer cellsMitomycin CCancer cellsMCF-7 human breast cancer cellsEMT6 cellsEMT6 mouse mammary tumor cellsHuman breast cancer cellsMCF-7 breast cancer cellsMouse mammary tumor cellsMammary tumor cellsMCF-7 cellsHuman fibroblastsMitomycin C treatmentTumor cellsReductive metabolitesDecarbamoyl mitomycin CNormal human fibroblasts
2006
The Interactions of Polarographic Measurements of Oxygen Tension and Histological Grade in Human Glioma
Lally BE, Rockwell S, Fischer DB, Collingridge DR, Piepmeier JM, Knisely JP. The Interactions of Polarographic Measurements of Oxygen Tension and Histological Grade in Human Glioma. The Cancer Journal 2006, 12: 461-466. PMID: 17207315, DOI: 10.1097/00130404-200611000-00005.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsHistological gradeHigh-grade gliomasLow-grade gliomasTumor oxygen tensionUnivariate analysisOxygen tensionGrade gliomasSignificant independent prognostic indicatorExtent of surgeryType of anesthesiaIndependent prognostic indicatorEppendorf pO2 histographTissue oxygen tensionNormal brain tissueImplications of hypoxiaOverall survivalProspective trialPatient ageEntire cohortPrognostic indicatorPatient genderPoor survivalMedian pO2PatientsPO2 histograph
2004
The interactions of polarographic measurements of oxygen tension and histological grade in human glioma and surrounding peritumoral brain tissue
Lally B, Rockwell S, Fischer D, Collingridge D, Piepmeier J, Knisely J. The interactions of polarographic measurements of oxygen tension and histological grade in human glioma and surrounding peritumoral brain tissue. International Journal Of Radiation Oncology • Biology • Physics 2004, 60: s194. DOI: 10.1016/j.ijrobp.2004.06.133.Peer-Reviewed Original ResearchCitationsRobert F. Kallman, 19222003
Brown M, Rockwell S. Robert F. Kallman, 19222003. Radiation Research 2004, 161: 120-122. DOI: 10.1667/rr3111.Peer-Reviewed Original ResearchAltmetric
2001
Bioreductive metabolism of mitomycin C in EMT6 mouse mammary tumor cells: cytotoxic and non-cytotoxic pathways, leading to different types of DNA adducts. The effect of dicumarol44Abbreviations: MC, mitomycin C; DIC, dicumarol; 2,7-DAM, 2,7-diaminomitosene; and XDH, xanthine dehydrogenase.
Palom Y, Belcourt M, Tang L, Mehta S, Sartorelli A, Pritsos C, Pritsos K, Rockwell S, Tomasz M. Bioreductive metabolism of mitomycin C in EMT6 mouse mammary tumor cells: cytotoxic and non-cytotoxic pathways, leading to different types of DNA adducts. The effect of dicumarol44Abbreviations: MC, mitomycin C; DIC, dicumarol; 2,7-DAM, 2,7-diaminomitosene; and XDH, xanthine dehydrogenase. Biochemical Pharmacology 2001, 61: 1517-1529. PMID: 11377381, DOI: 10.1016/s0006-2952(01)00609-8.Peer-Reviewed Original ResearchCitationsMeSH Keywords and Concepts
1999
The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation.
Rosen E, Fan S, Rockwell S, Goldberg I. The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation. Cancer Investigation 1999, 17: 56-72. PMID: 10999050, DOI: 10.3109/07357909909011718.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAcute DiseaseAnimalsApoptosisAtaxia Telangiectasia Mutated ProteinsBRCA1 ProteinCell CycleCell Cycle ProteinsCell Transformation, NeoplasticCellsCHO CellsCricetinaeCytokinesDNADNA DamageDNA RepairDNA-Binding ProteinsGenesGenes, BRCA1Genes, p53Growth SubstancesHumansNeoplasmsNeoplasms, Radiation-InducedOncogene ProteinsOncogenesProtein Serine-Threonine KinasesRadiation ToleranceRadiotherapySignal TransductionTime FactorsTumor Suppressor Protein p53Tumor Suppressor ProteinsConceptsGrowth factor signal transductionDNA damage responseCell cycle progressionCellular functionsDamage responseSignal transductionOverexpress proteinsCandidate genesCycle progressionMolecular mechanismsGenetic instabilityFunction mutationsCell typesCellular radiosensitivityCellular basisCellular mechanismsNormal tissuesGenesMutationsRadiosensitivityRecent studiesSevere normal tissue damageMild effectIndividual tumorsTransduction
Academic Achievements & Community Involvement
honor Distinguished Alumna
UnknownThe Pennsylvania State UniversityDetails06/01/2011United Stateshonor Distinguished Service Award
UnknownRadiation Research SocietyDetails09/01/2010United Stateshonor R F Kallman Lecturer
UnknownStanford UniversityDetails08/24/2010United Stateshonor Elected Fellow
UnknownAmerican Society of Radiation Oncology (ASTRO)Details01/01/2009United Stateshonor Elected Member
UnknownConnecticut Academy of Science & EngineeringDetails01/01/2007United States
News & Links
News
- May 23, 2016
Immunologist is associate dean for scientific affairs
- November 25, 2014
Sara Rockwell, PhD, FASTRO, Professor Emerita of Therapeutic Radiology, was honored with the Yale Cancer Center Lifetime Achievement Award.
- May 15, 2014
Abstract by group of Yale researchers accepted to "Best of Physics" session at the 56th annual ASTRO meeting.
- April 04, 2013Source: Medicine@Yale
Mapmakers of the living human body
Get In Touch
Contacts
Therapeutic Radiology
15 York Street PO Box 208040
New Haven, CT 06513
United States